Literature DB >> 24962218

The Regulation of TGFβ1 Induced Fibronectin EDA Exon Alternative Splicing in Human Renal Proximal Tubule Epithelial Cells.

Mysore Keshavmurthy Phanish1, Felicia Heidebrecht1, Mohammad E Nabi1, Nileshkumar Shah1, Ioana Niculescu-Duvaz1, Mark Edward Carl Dockrell1.   

Abstract

The EDA+ splice variant of fibronectin (Fn) is an early and important component of the extracellular matrix in renal fibrosis. In this work, we investigate cellular mechanisms of EDA+Fn production in human primary proximal tubule epithelial cells (PTECs). TGFβ1-induced EDA+Fn production was assessed by immunocytochemistry, PCR, and Western blotting. SRp40 knockdown was achieved by siRNA. The role of the PI3 kinase-AKT signalling and splicing regulatory protein SRp40 in the production of EDA+Fn was studied by using the chemical inhibitor LY294002 and siRNA targeted to SRp40 respectively. Interaction between PI3 kinase-AKT signalling and SRp40 were assessed by immunofluorescence and immunoprecipitation. To assess the specificity of SRp40 in regulating the splicing of EDA+ exon, we studied the effect of SRp40 knockdown on TGFβ1 induced splicing of FGF receptor 2. Primary human PTECs expressed EDA+ and EDA- Fn. TGFβ1 treatment resulted in increases in the production and deposition of EDA+ Fn as well as an increase in the ratio of EDA+/EDA- Fn mRNA. The TGFβ1 induced EDA+ production was dependent on PI3 kinase-AKT signalling and SRp40 expression. Immunoprecipitation experiments demonstrated direct binding between AKT and SRp40 with an increase in the amount of SRp40 bound to AKT upon TGFβ1 treatment. TGFβ1 treatment resulted in reduction in the FGF receptor2 IIIb splice variant which was unaffected by SRp40 knockdown. In this work, we have presented the first evidence for the regulation of Fn pre-mRNA splicing by PI3 kinase-AKT signalling and SRp40 in human PTECs. Targeting the splicing of Fn pre-mRNA to skip the EDA exon is an attractive option to combat fibrosis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24962218     DOI: 10.1002/jcp.24703

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors.

Authors:  Francois Bordeleau; Joseph P Califano; Yashira L Negrón Abril; Brooke N Mason; Danielle J LaValley; Sandra J Shin; Robert S Weiss; Cynthia A Reinhart-King
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

2.  Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment.

Authors:  Joshua S McLane; Lee A Ligon
Journal:  Biophys J       Date:  2015-07-21       Impact factor: 4.033

Review 3.  Alternative Splicing in CKD.

Authors:  Megan Stevens; Sebastian Oltean
Journal:  J Am Soc Nephrol       Date:  2016-01-13       Impact factor: 10.121

4.  Identification of splice regulators of fibronectin-EIIIA and EIIIB by direct measurement of exon usage in a flow-cytometry based CRISPR screen.

Authors:  Jessica A Hensel; Brent D Heineman; Amy L Kimble; Evan R Jellison; Bo Reese; Patrick A Murphy
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

Review 5.  TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.

Authors:  Bedair Dewidar; Christoph Meyer; Steven Dooley; And Nadja Meindl-Beinker
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.